Skip to main content

Table 1 Information about human postmortem tissue samples

From: Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant

A152T carriers Noncarriers
Code Braak Age; Gender Code Braak Age; Gender
ADv1 5 81; F AD1 6 80; F
ADv2 6 96; M AD2 5.5 91; M
ADv3 6 86; M AD3 5 84; M
ADv4 4.5 80; F AD4 5 80; F
ADv5 6 91; F AD5 6 83; F
ADv6 5 67; M AD6 6 61; M
PSPv1 2 67; M PSP1 1 69; M
PSPv2 3 74; F PSP2 3 74; M
PSPv3 1 81; F PSP3 1 80; F
PSPv4 3 77; M PSP4 2.5 76; M
PSPv5 3 77; F PSP5 3.5 81; F
LBDv1 3 75; M LBD1 3.5 72; M
LBDv2 2.5 72; M LBD2 0 72; M
CBDv1 3 68; F CBD1 3 67; F
fMNDv1 (C9+) 0 62; F fMND1 (C9+) 2 55; F
  1. AD Alzheimer’s disease, PSP Progressive supranuclear palsy, LBD Lewy body dementia, CBD Corticobasal degeneration, fMND (C9+) Frontotemporal lobar degeneration with motor neuron disease associated with C9ORF72 mutation